2-Year Outcomes of an Atrial Shunt Device in HFpEF/HFmrEF: Results From REDUCE LAP-HF II

- Gustafsson, Finn, Petrie, Mark C., Fail, Peter S., Chung, Eugene S., Lurz, Philipp, Lilly, Scott, Kaye, David M., Cleland, John G. F., Cikes, Maja, Leon, Martin B., Cutlip, Donald E., van Veldhuisen, Dirk J., Komtebedde, Jan, Solomon, Scott D., Shah, SJ, Swarup, Vijendra, Winkler, Sebastian, Hasenfuß, Gerd, Borlaug, Barry A., Mohan, Rajeev C., Flaherty, James D., Sverdlov, Aaron L.

Exercise-Induced Left Atrial Hypertension in Heart Failure With Preserved Ejection Fraction

- Litwin, Sheldon E., Komtebedde, Jan, Sverdlov, Aaron L., Fail, Peter, Chung, Eugene S., Kaye, David M., Blair, John, Eicher, Jean-Christophe, Hummel, Scott L., Zirlik, Andreas, Westenfeld, Ralf, Hayward, Christopher, Hu, Mo, Gorter, Thomas M., Demers, C, Shetty, R, Lewis, G, Starling, RC, Patel, S, Gupta, DK, Morsli, H, Penicka, M, Cikes, M, Burkhoff, Daniel, Gustafsson, F, Silvestry, FE, Rowin, EJ, Cutlip, DE, Leon, MB, Kitzman, DW, Kleber, FX, Shah, SJ, REDUCE LAP-HF Investigators and Research Staff,, Hasenfuß, Gerd, Borlaug, Barry A., Solomon, Scott D., Zile, Michael R., Mohan, Rajeev C., Khawash, Rami

Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial

- Shah, Sanjiv J., Borlaug, Barry A., Litwin, Sheldon E., Lurz, Philipp, Massaro, Joseph M., Mohan, Rajeev C., Ricciardi, Mark J., Solomon, Scott D., Sverdlov, Aaron L., Swarup, Vijendra, van Veldhuisen, Dirk J., Winkler, Sebastian, Chung, Eugene S., Leon, Martin B., REDUCE LAP-HF II investigators,, Cutlip, Donald E., Debonnaire, Philippe, Fail, Peter S., Gao, Qi, Hasenfuß, Gerd, Kahwash, Rami, Kaye, David M.

Relation between QT interval variability and cardiac sympathetic activity in hypertension

- Baumert, Mathias, Schlaich, Markus P., Nalivaiko, Eugene, Lambert, Elisabeth, Sari, Carolina Ika, Kaye, David M., Elser, Murray D., Sanders, Prashanthan, Lambert, Gavin